Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis
Study Overview In this investigation, researchers focused on the presence of residual inflammation within the cerebrospinal fluid (CSF) of patients […]
